Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

CROMIS-2 collaborators, Duncan Wilson, Gareth Ambler, Clare Shakeshaft, Martin M. Brown, Andreas Charidimou, Rustam Al-Shahi Salman, Gregory Y.H. Lip, Hannah Cohen, Gargi Banerjee, Henry Houlden, Mark J. White, Tarek A. Yousry, Kirsty Harkness, Enrico Flossmann, Nigel Smyth, Louise J. Shaw, Elizabeth Warburton, Keith W. Muir, Hans Rolf JägerDavid J. Werring*, John Aeron-Thomas, Prasanna Aghoram, Elaine Amis, Peter Anderton, Sreeman Andole, Ijaz Anwar, John Bamford, Azra Banaras, Aian Barry, Ruth Bellfied, Aienne Benford, Ajay Bhalla, Maneesh Bhargava, Biju Bhaskaran, Neelima Bhupathiraju, Jonathan Birns, Aian Blight, Angie Bowring, Ellen Brown, David Bruce, Amanda Buck, Kerry Bunworth, Ilse Burger, Laura Burgess, Mathew Burn, Evelyn Burssens, Mauian Burton, Nicola Butler, Denise Button, Michael Carpenter

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study'. Together they form a unique fingerprint.

Medicine & Life Sciences